MCG101-induced cancer anorexia-cachexia features altered expression of hypothalamic Nucb2 and Cartpt and increased plasma levels of cocaine- and amphetamine-regulated transcript peptides

Burgos,Jonathan  R.; Iresjö,Britt-Marie; Smedh,Ulrika

doi:10.3892/or.2016.4558

MCG101-induced cancer anorexia-cachexia features altered expression of hypothalamic Nucb2 and Cartpt and increased plasma levels of cocaine- and amphetamine-regulated transcript peptides

Authors:
- Jonathan R. Burgos
- Britt-Marie Iresjö
- Ulrika Smedh
View Affiliations

Affiliations: Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, 413 45 Gothenburg, Sweden
Published online on: January 14, 2016 https://doi.org/10.3892/or.2016.4558
Pages: 2425-2430

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to explore central and peripheral host responses to an anorexia-cachexia producing tumor. We focused on neuroendocrine anorexigenic signals in the hypothalamus, brainstem, pituitary and from the tumor per se. Expression of mRNA for corticotropin-releasing hormone (CRH), cocaine- and amphetamine-regulated transcript (CART), nesfatin-1, thyrotropin (TSH) and the TSH receptor were explored. In addition, we examined changes in plasma TSH, CART peptides (CARTp) and serum amyloid P component (SAP). C57BL/6 mice were implanted with MCG101 tumors or sham-treated. A sham-implanted, pair‑fed (PF) group was included to delineate between primary tumor and secondary effects from reduced feeding. Food intake and body weight were measured daily. mRNA levels from microdissected mouse brain samples were assayed using qPCR, and plasma levels were determined using ELISA. MCG101 tumors expectedly induced anorexia and loss of body weight. Tumor-bearing (TB) mice exhibited an increase in nesfatin-1 mRNA as well as a decrease in CART mRNA in the paraventricular area (PVN). The CART mRNA response was secondary to reduced caloric intake whereas nesfatin-1 mRNA appeared to be tumor-specifically induced. In the pituitary, CART and TSH mRNA were upregulated in the TB and PF animals compared to the freely fed controls. Plasma levels for CARTp were significantly elevated in TB but not PF mice whereas levels of TSH were unaffected. The plasma CARTp response was correlated to the degree of inflammation represented by SAP. The increase in nesfatin-1 mRNA in the PVN highlights nesfatin-1 as a plausible candidate for causing tumor-induced anorexia. CART mRNA expression in the PVN is likely an adaptation to reduced caloric intake secondary to a cancer anorexia-cachexia syndrome (CACS)‑inducing tumor. The MCG101 tumor did not express CART mRNA, thus the elevation of plasma CARTp is host derived and likely driven by inflammation.

View Figures

View References

1	Bruera E: ABC of palliative care. Anorexia, cachexia, and nutrition. BMJ. 315:1219–1222. 1997. View Article : Google Scholar : PubMed/NCBI
2	Tisdale MJ: Cachexia in cancer patients. Nat Rev Cancer. 2:862–871. 2002. View Article : Google Scholar : PubMed/NCBI
3	Tisdale MJ: Cancer cachexia. Curr Opin Gastroenterol. 26:146–151. 2010. View Article : Google Scholar
4	Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, et al: Definition and classification of cancer cachexia: An international consensus. Lancet Oncol. 12:489–495. 2011. View Article : Google Scholar : PubMed/NCBI
5	Konsman JP and Blomqvist A: Forebrain patterns of c-Fos and FosB induction during cancer-associated anorexia-cachexia in rat. Eur J Neurosci. 21:2752–2766. 2005. View Article : Google Scholar : PubMed/NCBI
6	Ruud J and Blomqvist A: Identification of rat brainstem neuronal structures activated during cancer-induced anorexia. J Comp Neurol. 504:275–286. 2007. View Article : Google Scholar : PubMed/NCBI
7	Lonnroth C, Svaninger G, Gelin J, Cahlin C, Iresjo B, Cvetkovska E, Edstrom S, Andersson M, Svanberg E and Lundholm K: Effects related to indomethacin prolonged survival and decreased tumor-growth in a mouse-tumor model with cytokine dependent cancer cachexia. Int J Oncol. 7:1405–1413. 1995.PubMed/NCBI
8	Lundholm K, Karlberg I, Ekman L, Edström S and Scherstén T: Evaluation of anorexia as the cause of altered protein synthesis in skeletal muscles from nongrowing mice with sarcoma. Cancer Res. 41:1989–1996. 1981.PubMed/NCBI
9	Cahlin C, Körner A, Axelsson H, Wang W, Lundholm K and Svanberg E: Experimental cancer cachexia: The role of hostderived cytokines interleukin (IL)-6, IL-12, interferon-gamma, and tumor necrosis factor alpha evaluated in gene knockout, tumor-bearing mice on C57 Bl background and eicosanoid-dependent cachexia. Cancer Res. 60:5488–5493. 2000.PubMed/NCBI
10	Iresjö BM, Svanberg E and Lundholm K: Reevaluation of amino acid stimulation of protein synthesis in murine- and human-derived skeletal muscle cells assessed by independent techniques. Am J Physiol Endocrinol Metab. 288:E1028–E1037. 2005. View Article : Google Scholar
11	Lin MT, Chu PC and Leu SY: Effects of TSH, TRH, LH and LHRH on thermoregulation and food and water intake in the rat. Neuroendocrinology. 37:206–211. 1983. View Article : Google Scholar : PubMed/NCBI
12	Kristensen P, Judge ME, Thim L, Ribel U, Christjansen KN, Wulff BS, Clausen JT, Jensen PB, Madsen OD, Vrang N, et al: Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature. 393:72–76. 1998. View Article : Google Scholar : PubMed/NCBI
13	Grill HJ, Markison S, Ginsberg A and Kaplan JM: Long-term effects on feeding and body weight after stimulation of forebrain or hindbrain CRH receptors with urocortin. Brain Res. 867:19–28. 2000. View Article : Google Scholar : PubMed/NCBI
14	Oh-I S, Shimizu H, Satoh T, Okada S, Adachi S, Inoue K, Eguchi H, Yamamoto M, Imaki T, Hashimoto K, et al: Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature. 443:709–712. 2006. View Article : Google Scholar : PubMed/NCBI
15	Bonnet MS, Djelloul M, Tillement V, Tardivel C, Mounien L, Trouslard J, Troadec JD and Dallaporta M: Central NUCB2/nesfatin-1-expressing neurones belong to the hypothalamic-brain-stem circuitry activated by hypoglycaemia. J Neuroendocrinol. 25:1–13. 2013. View Article : Google Scholar
16	Schnydrig S, Korner L, Landweer S, Ernst B, Walker G, Otten U and Kunz D: Peripheral lipopolysaccharide administration transiently affects expression of brain-derived neurotrophic factor, corticotropin and proopiomelanocortin in mouse brain. Neurosci Lett. 429:69–73. 2007. View Article : Google Scholar : PubMed/NCBI
17	Sergeyev V, Broberger C and Hökfelt T: Effect of LPS administration on the expression of POMC, NPY, galanin, CART and MCH mRNAs in the rat hypothalamus. Brain Res Mol Brain Res. 90:93–100. 2001. View Article : Google Scholar : PubMed/NCBI
18	van Zeijl CJ, Surovtseva OV, Wiersinga WM, Fliers E and Boelen A: Acute inflammation increases pituitary and hypothalamic glycoprotein hormone subunit B5 mRNA expression in association with decreased thyrotrophin receptor mRNA expression in mice. J Neuroendocrinol. 23:310–319. 2011. View Article : Google Scholar : PubMed/NCBI
19	Aydin S: Multi-functional peptide hormone NUCB2/nesfatin-1. Endocrine. 44:312–325. 2013. View Article : Google Scholar : PubMed/NCBI
20	Maejima Y, Shimomura K, Sakuma K, Yang Y, Arai T, Mori M and Yada T: Paraventricular nucleus nesfatin-1 neurons are regulated by pituitary adenylate cyclase-activating polypeptide (PACAP). Neurosci Lett. 551:39–42. 2013. View Article : Google Scholar : PubMed/NCBI
21	Cetinkaya H, Karagöz B, Bilgi O, Ozgün A, Tunçel T, Emirzeoğlu L, Top C and Kandemir EG: Nesfatin-1 in advanced lung cancer patients with weight loss. Regul Pept. 181:1–3. 2013. View Article : Google Scholar
22	Kohno D, Nakata M, Maejima Y, Shimizu H, Sedbazar U, Yoshida N, Dezaki K, Onaka T, Mori M and Yada T: Nesfatin-1 neurons in paraventricular and supraoptic nuclei of the rat hypothalamus coexpress oxytocin and vasopressin and are activated by refeeding. Endocrinology. 149:1295–1301. 2008. View Article : Google Scholar
23	Hashimoto H, Azuma Y, Kawasaki M, Fujihara H, Onuma E, Yamada-Okabe H, Takuwa Y, Ogata E and Ueta Y: Parathyroid hormone-related protein induces cachectic syndromes without directly modulating the expression of hypothalamic feeding-regulating peptides. Clin Cancer Res. 13:292–298. 2007. View Article : Google Scholar : PubMed/NCBI
24	de Rijke CE, Hillebrand JJ, Verhagen LA, Roeling TA and Adan RA: Hypothalamic neuropeptide expression following chronic food restriction in sedentary and wheel-running rats. J Mol Endocrinol. 35:381–390. 2005. View Article : Google Scholar : PubMed/NCBI
25	Nakhate KT, Kokare DM, Singru PS, Taksande AG, Kotwal SD and Subhedar NK: Hypothalamic cocaine- and amphetamine-regulated transcript peptide is reduced and fails to modulate feeding behavior in rats with chemically-induced mammary carcinogenesis. Pharmacol Biochem Behav. 97:340–349. 2010. View Article : Google Scholar : PubMed/NCBI
26	Persson H, Bennegård K, Lundberg PA, Svaninger G and Lundholm K: Thyroid hormones in conditions of chronic malnutrition. A study with special reference to cancer cachexia. Ann Surg. 201:45–52. 1985.PubMed/NCBI
27	Svaninger G, Lundberg PA and Lundholm K: Thyroid hormones and experimental cancer cachexia. J Natl Cancer Inst. 77:555–561. 1986.PubMed/NCBI
28	Bech P, Winstanley V, Murphy KG, Sam AH, Meeran K, Ghatei MA and Bloom SR: Elevated cocaine- and amphetamine-regulated transcript immunoreactivity in the circulation of patients with neuroendocrine malignancy. J Clin Endocrinol Metab. 93:1246–1253. 2008. View Article : Google Scholar : PubMed/NCBI
29	Landerholm K, Falkmer SE, Järhult J, Sundler F and Wierup N: Cocaine- and amphetamine-regulated transcript in neuroendocrine tumors. Neuroendocrinology. 94:228–236. 2011. View Article : Google Scholar : PubMed/NCBI
30	Landerholm K, Shcherbina L, Falkmer SE, Jarhult J and Wierup N: Expression of cocaine- and amphetamine-regulated transcript is associated with worse survival in small bowel carcinoid tumors. Clin Cancer Res. 18:3668–3676. 2012. View Article : Google Scholar : PubMed/NCBI
31	Jensen PB, Kristensen P, Clausen JT, Judge ME, Hastrup S, Thim L, Wulff BS, Foged C, Jensen J, Holst JJ, et al: The hypothalamic satiety peptide CART is expressed in anorectic and non-anorectic pancreatic islet tumors and in the normal islet of Langerhans. FEBS Lett. 447:139–143. 1999. View Article : Google Scholar : PubMed/NCBI
32	Okumura T, Yamada H, Motomura W and Kohgo Y: Cocaineamphetamine-regulated transcript (CART) acts in the central nervous system to inhibit gastric acid secretion via brain corticotropin-releasing factor system. Endocrinology. 141:2854–2860. 2000.PubMed/NCBI
33	Skibicka KP, Alhadeff AL and Grill HJ: Hindbrain cocaine-and amphetamine-regulated transcript induces hypothermia mediated by GLP-1 receptors. J Neurosci. 29:6973–6981. 2009. View Article : Google Scholar : PubMed/NCBI
34	Tebbe JJ, Ortmann E, Schumacher K, Mönnikes H, Kobelt P, Arnold R and Schäfer MK: Cocaine- and amphetamine-regulated transcript stimulates colonic motility via central CRF receptor activation and peripheral cholinergic pathways in fed, conscious rats. Neurogastroenterol Motil. 16:489–496. 2004. View Article : Google Scholar : PubMed/NCBI